Jeffrey LaRose, Chief Scientific Officer at HeartWare International, Inc. (HTWR), sold 205 shares at $32.41 ($7K) on 2016-02-24, disclosed to the SEC on 2016-02-25.
Scheduled sale ($7k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| HTWR | SELL | 2015-12-23 | $57K | — | Filing → |
| HTWR | SELL | 2015-02-26 | $30K | — | Filing → |
| HTWR | SELL | 2015-02-10 | $42K | — | Filing → |